Drug and Medication Analysis & Statistics in Europe Countries, November 2014

You might be interested in: Drug, Vaccine, Smoking Cessation, more »

1-50 of about 1 500 reports

Purchase Reports From Reputable Market Research Publishers

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: While we lowered our projections for Hungary's pharmaceutical industry in response to the government's structural reform programme at the start of 2011, we continue to believe the reported magnitude ...

  • Industries : Drug and Medication
  • Countries : Hungary
Latvia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Latvia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: Latvia’s attractiveness to multinationals will continue to be negatively impacted by the government’s cost-containment measures and the wider macroeconomic performance, especially as much ...

  • Industries : Drug and Medication
  • Countries : Latvia
Romania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Romania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: The introduction of a revised claw-back mechanism in Romania has angered drugmakers operating in the industry . BMI believes the current form of the legislation is overly simplistic and punishes ...

  • Industries : Drug and Medication
  • Countries : Romania
Italy Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Italy Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: Under pressure from jittery financial industries, a new Italian government led by Prime Minister Mario Monti was sworn in on November 16 2011, just four days after the resignation of Silvio Berlusconi. ...

  • Industries : Drug and Medication
  • Countries : Italy
Sweden Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Sweden Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: Sweden’s pharmaceutical industry is expected to grow weakly over the coming years as the government’s attempts to contain health care costs focus on pharmaceutical expenditure. Having said ...

  • Industries : Drug and Medication
  • Countries : Sweden
Croatia Pharmaceuticals and Healthcare Report Q1 2015

Croatia Pharmaceuticals and Healthcare Report Q1 2015

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Drug shortages have been reported for certain drugs such as antibiotics as their prices make them unprofitable for manufacturers. The HZZO continues to face ...

  • Industries : Drug and Medication
  • Countries : Croatia
Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: Although Slovenia is a small pharmaceutical industry, the country boasts a well-developed healthcare system and solid infrastructure, propped up by high per capita spending on healthcare. However, ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Moldova Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Moldova Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Moldova is projection to deliver a solid US dollar compound annual growth rate (CAGR) of just under 8% for the period from 2010 to 2015, below its rate earlier this decade. The industry is generally ...

  • Industries : Drug and Medication
  • Countries : Moldova, Republic Of
Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Despite the threat of austerity measures, the Swiss government’s focus on cost-containment within the pharmaceuticals and healthcare segment and the impact of generic competition as a result ...

  • Industries : Drug and Medication
  • Countries : Switzerland
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014

United Kingdom Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: The decline in NHS pharmaceutical expenditure in 2013, despite an increase in prescription numbers, does not come as a surprise and is expected to continue beyond 2014. This drop in spending ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Finland Pharmaceuticals and Healthcare Report Q4 2104

Finland Pharmaceuticals and Healthcare Report Q4 2104

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: An ageing population and the subsequent increased consumption of high-value prescription medicines for the treatment of long-term illnesses will place a greate ...

  • Industries : Drug and Medication
  • Countries : Finland
Greece Pharmaceuticals and Healthcare Report Q4 2104

Greece Pharmaceuticals and Healthcare Report Q4 2104

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The pharmaceutical and healthcare industry in Greece will continue to contract over the remainder of 2014. The government will seek to reduce public spending ...

  • Industries : Drug and Medication
  • Countries : Greece
Russia Pharmaceuticals and Healthcare Report Q4 2104

Russia Pharmaceuticals and Healthcare Report Q4 2104

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in the country. With the EU and the US applying further sanctions, the ...

  • Industries : Drug and Medication
  • Countries : Russian Federation
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Our expectations that the Czech Republic would return to moderately positive growth in 2011, before seeing negligible growth in 2012 have been revised downwards, and we now project very low growth ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Serbia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Serbia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Serbia’s medium- to-longer term convergence with the wider European industry will stimulate pharmaceutical demand, especially as the country’s economic prospects improve over the coming years. ...

  • Industries : Drug and Medication
  • Countries : Serbia and Montenegro
Spain Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Spain Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: We believe the Spanish government's decision to implement further austerity measures is a necessary and prudent course of action. The country still has the third highest budget deficit in the ...

  • Industries : Drug and Medication
  • Countries : Spain
Norway Pharmaceuticals and Healthcare Report Q4 2014

Norway Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: While the Norwegian government's pro-generic stance will continue to support growth in the country's off-patent medicines market, we highlight that the loss of market value in the patented drugs ...

  • Industries : Drug and Medication
  • Countries : Norway
Ukraine Pharmaceuticals and Healthcare Report Q4 2014

Ukraine Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Ukraine is currently experiencing geopolitical tension with its neighbour Russia, which is actively fomenting unrest in the east of Ukraine. In 2014, owing to the severe devaluation of the hryvnia ...

  • Industries : Drug and Medication
  • Countries : Ukraine
Belarus Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: All indicators point to a period of prolonged economic and political upheaval in Belarus, with the pharmaceutical industry battered by a combination of high inflation and currency devaluation ...

  • Industries : Drug and Medication
  • Countries : Belarus
Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: In terms of its attractiveness to investors, Slovenia remains a mid-tier pharmaceutical industry within Emerging Europe. While not immune from economic factors and government austerity drives, ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Austria Pharmaceuticals and Healthcare Report Q4 2014

Austria Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: BMI has upwardly revised its pharmaceutical and healthcare forecasts for Austria, reflecting the country's improving economic prospects and attractiveness of ...

  • Industries : Drug and Medication
  • Countries : Austria
Poland Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Poland Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: Late-stage revisions to Poland's pharmaceutical reimbursement act have been broadly positive for pharmaceutical industry players operating in this industry . However, the central premise of the ...

  • Industries : Drug and Medication
  • Countries : Poland
Romania Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Romania Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: We continue to expect Romania's pharmaceutical industry to return to high single-digit growth in 2011 and 2012. However, weaker than expected drug price inflation in Q211 has resulted in a downward ...

  • Industries : Drug and Medication
  • Countries : Romania
France Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

France Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: France is one of the leading global pharmaceutical industry s by size, propped up by its large population of just under 63mn. The French are traditionally fond of patented and branded drugs and ...

  • Industries : Drug and Medication
  • Countries : France
Germany Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Germany Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: Despite the threat of austerity measures, the government’s focus on cost-containment within the pharmaceuticals and healthcare segment and the impact of generic competition as a result of the ...

  • Industries : Drug and Medication
  • Countries : Germany
Hungary Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: We continue to project that the Széll Kálmán structural reforms plan, which aims to achieve savings of HUF120bn (US Dollar 580mn) over three years from Hungary’s medicine budget will lead ...

  • Industries : Drug and Medication
  • Countries : Hungary
Italy Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Italy Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: We believe the Italian government's decision to implement further austerity measures is a necessary and prudent course of action – Italy maintains one of the largest sovereign debt loads in ...

  • Industries : Drug and Medication
  • Countries : Italy
Sweden Pharmaceuticals and Healthcare Report Q4 2014

Sweden Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: As Sweden's population grows older and demands for healthcare provision increase, the government is facing a concerning scenario of rapidly increasing expenditure ...

  • Industries : Drug and Medication
  • Countries : Sweden
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: The Netherlands has a well established pharmaceutical market with strength in vaccines and biologics. As a result, the country has the necessary infrastructure and skilled workforce to be regarded ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Latvia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Latvia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: Latvia's disease profile and relatively low per-capita consumption of pharmaceuticals (compared with the rest of developed Europe) is a clear illustration of the need for innovative medicines. ...

  • Industries : Drug and Medication
  • Countries : Latvia
About 1 900 reports

Download Unlimited Documents from Trusted Public Sources

Testosterone Analysis in the UK and Cameroon

  • Cross-cultural Variation in Women's Preferences for Cues to Sex-...
  • November 2014
    4 pages
  • Testosterone  

    Hormone  

  • United Kingdom  

    Cameroon  

View report >

Drug Industry In The Uk

November 2014

2 Companies

Read our Company Profiles


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.